The 5th Exosome Based Therapeutic Development Summit returns with a refreshed program, with data-driven insights from those pioneering the field who are dedicated to the clinical translation and commercialization of exosome-based therapeutics across a broad range of disease indications.

This year features a brand-new focus day on analytical development, diving into characterization assays, purification, and potency assays to enable robust translation into the clinic.

This is the most comprehensive, end-to-end meeting for industry personnel who are looking to fine-tune molecular components of exosomes, achieve GMP manufacturing of EVs for clinical applications, and successfully deliver payloads to the target tissue by evaluating route of administration to accelerate candidates towards commercialization.

The 2023 conference covers:

• Emerging standardized analytical strategies for optimized characterization, purification, and isolation to improve batch consistency and reproducibility towards successful scale-up
• Key pre-clinical and clinical updates across a range of therapeutic areas
• The latest advancements of targeted delivery and therapeutic payloads
• The challenges of large-scale manufacturing
• Navigating the complex regulatory landscape across the drug development timeline

View the full agenda here: https://ter.li/q4fnpd